Medication adherence as a predictor of 30-day hospital readmissions

Olga Z Rosen,1 Rachel Fridman,2 Bradley T Rosen,3,4 Rita Shane,1 Joshua M Pevnick4,5 1Department of Pharmacy Services, Cedars-Sinai Medical Center, 2Resources & Outcomes Management, Cedars-Sinai Health System, 3Department of Medicine, ISP Hospitalist Service, Cedars-Sinai Medical Center, 4U...

Full description

Bibliographic Details
Main Authors: Rosen OZ, Fridman R, Rosen BT, Shane R, Pevnick JM
Format: Article
Language:English
Published: Dove Medical Press 2017-04-01
Series:Patient Preference and Adherence
Subjects:
Online Access:https://www.dovepress.com/medication-adherence-as-a-predictor-of-30-day-hospital-readmissions-peer-reviewed-article-PPA
id doaj-b5906686c7f84bdf8a6a84b112878d4e
record_format Article
spelling doaj-b5906686c7f84bdf8a6a84b112878d4e2020-11-24T23:38:18ZengDove Medical PressPatient Preference and Adherence1177-889X2017-04-01Volume 1180181032504Medication adherence as a predictor of 30-day hospital readmissionsRosen OZFridman RRosen BTShane RPevnick JMOlga Z Rosen,1 Rachel Fridman,2 Bradley T Rosen,3,4 Rita Shane,1 Joshua M Pevnick4,5 1Department of Pharmacy Services, Cedars-Sinai Medical Center, 2Resources & Outcomes Management, Cedars-Sinai Health System, 3Department of Medicine, ISP Hospitalist Service, Cedars-Sinai Medical Center, 4University of California, Los Angeles School of Medicine, 5Division of General Internal Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA Purpose: The aim of this study was to test whether patient medication adherence, a modifiable risk factor obtainable at hospital admission, predicts readmission within 30 days. Patients and methods: We used a retrospective cohort study design to test whether patient medication adherence to all chronic medications, as determined by the 4-item Morisky Medication Adherence Scale (MMAS-4) administered by a pharmacist at the time of hospital admission, predicts 30-day readmissions. We compared readmission rates among 385 inpatients who had their adherence assessed from February 1, 2013, to January 31, 2014. Multiple logistic regression was used to examine the benefit of adding medication adherence to previously published variables that have been shown to predict 30-day readmissions. Results: Patients with low and intermediate adherence (combined) had readmission rates of 20.0% compared to a readmission rate of 9.3% for patients with high adherence (P=0.005). By adding MMAS-4 data to previously published variables that have been shown to predict 30-day readmissions, we found that patients with low and intermediate medication adherence had an adjusted 2.54-fold higher odds of readmission compared to those in patients with high adherence (95% confidence interval [CI]: 1.32–4.90, P=0.005). The model’s predictive power, as measured by the c-statistic, improved from 0.65 to 0.70 after adding adherence. Conclusion: Because medication adherence assessed at hospital admission was independently associated with 30-day readmission risk, it offers potential for targeting interventions to improve adherence. Keywords: rehospitalization, predictive model, transition of care, care transitions, nonadherence, MMAS-4https://www.dovepress.com/medication-adherence-as-a-predictor-of-30-day-hospital-readmissions-peer-reviewed-article-PPARehospitalizationPredictive modelTransition of careCare transitionsNonadherenceMMAS-4
collection DOAJ
language English
format Article
sources DOAJ
author Rosen OZ
Fridman R
Rosen BT
Shane R
Pevnick JM
spellingShingle Rosen OZ
Fridman R
Rosen BT
Shane R
Pevnick JM
Medication adherence as a predictor of 30-day hospital readmissions
Patient Preference and Adherence
Rehospitalization
Predictive model
Transition of care
Care transitions
Nonadherence
MMAS-4
author_facet Rosen OZ
Fridman R
Rosen BT
Shane R
Pevnick JM
author_sort Rosen OZ
title Medication adherence as a predictor of 30-day hospital readmissions
title_short Medication adherence as a predictor of 30-day hospital readmissions
title_full Medication adherence as a predictor of 30-day hospital readmissions
title_fullStr Medication adherence as a predictor of 30-day hospital readmissions
title_full_unstemmed Medication adherence as a predictor of 30-day hospital readmissions
title_sort medication adherence as a predictor of 30-day hospital readmissions
publisher Dove Medical Press
series Patient Preference and Adherence
issn 1177-889X
publishDate 2017-04-01
description Olga Z Rosen,1 Rachel Fridman,2 Bradley T Rosen,3,4 Rita Shane,1 Joshua M Pevnick4,5 1Department of Pharmacy Services, Cedars-Sinai Medical Center, 2Resources & Outcomes Management, Cedars-Sinai Health System, 3Department of Medicine, ISP Hospitalist Service, Cedars-Sinai Medical Center, 4University of California, Los Angeles School of Medicine, 5Division of General Internal Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA Purpose: The aim of this study was to test whether patient medication adherence, a modifiable risk factor obtainable at hospital admission, predicts readmission within 30 days. Patients and methods: We used a retrospective cohort study design to test whether patient medication adherence to all chronic medications, as determined by the 4-item Morisky Medication Adherence Scale (MMAS-4) administered by a pharmacist at the time of hospital admission, predicts 30-day readmissions. We compared readmission rates among 385 inpatients who had their adherence assessed from February 1, 2013, to January 31, 2014. Multiple logistic regression was used to examine the benefit of adding medication adherence to previously published variables that have been shown to predict 30-day readmissions. Results: Patients with low and intermediate adherence (combined) had readmission rates of 20.0% compared to a readmission rate of 9.3% for patients with high adherence (P=0.005). By adding MMAS-4 data to previously published variables that have been shown to predict 30-day readmissions, we found that patients with low and intermediate medication adherence had an adjusted 2.54-fold higher odds of readmission compared to those in patients with high adherence (95% confidence interval [CI]: 1.32–4.90, P=0.005). The model’s predictive power, as measured by the c-statistic, improved from 0.65 to 0.70 after adding adherence. Conclusion: Because medication adherence assessed at hospital admission was independently associated with 30-day readmission risk, it offers potential for targeting interventions to improve adherence. Keywords: rehospitalization, predictive model, transition of care, care transitions, nonadherence, MMAS-4
topic Rehospitalization
Predictive model
Transition of care
Care transitions
Nonadherence
MMAS-4
url https://www.dovepress.com/medication-adherence-as-a-predictor-of-30-day-hospital-readmissions-peer-reviewed-article-PPA
work_keys_str_mv AT rosenoz medicationadherenceasapredictorof30dayhospitalreadmissions
AT fridmanr medicationadherenceasapredictorof30dayhospitalreadmissions
AT rosenbt medicationadherenceasapredictorof30dayhospitalreadmissions
AT shaner medicationadherenceasapredictorof30dayhospitalreadmissions
AT pevnickjm medicationadherenceasapredictorof30dayhospitalreadmissions
_version_ 1725517063045251072